# Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

> **NCT02463344** · — · COMPLETED · sponsor: **Astellas Institute for Regenerative Medicine** · enrollment: 11 (actual)

## Conditions studied

- Age-Related Macular Degeneration

## Interventions

- **BIOLOGICAL:** MA09-hRPE

## Key facts

- **NCT ID:** NCT02463344
- **Lead sponsor:** Astellas Institute for Regenerative Medicine
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-25
- **Primary completion:** 2019-08-19
- **Final completion:** 2019-08-19
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02463344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02463344, "Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02463344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*